Inverse association between total testosterone concentrations, incident hypertension and blood pressure
暂无分享,去创建一个
H. Völzke | S. Baumeister | S. Felix | R. Haring | H. Wallaschofski | M. Nauck | M. Dörr | R. Rettig | S. Torkler
[1] Jeroen J. Bax,et al. 2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, Blood pressure.
[2] W. Rathmann,et al. Cohort profile: the study of health in Pomerania. , 2011, International journal of epidemiology.
[3] H. Völzke,et al. Prospective association of low total testosterone concentrations with an adverse lipid profile and increased incident dyslipidemia , 2011, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[4] H. Völzke,et al. Prevalence, incidence and risk factors of testosterone deficiency in a population-based cohort of men: results from the study of health in Pomerania , 2010, The aging male : the official journal of the International Society for the Study of the Aging Male.
[5] U. John,et al. Subclinical hyperthyroidism and blood pressure in a population-based prospective cohort study. , 2009, European journal of endocrinology.
[6] A. Traish,et al. The dark side of testosterone deficiency: III. Cardiovascular disease. , 2009, Journal of andrology.
[7] G. Brabant,et al. Associations of anthropometric parameters with serum TSH, prolactin, IGF-I, and testosterone levels: results of the study of health in Pomerania (SHIP). , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[8] H. Völzke,et al. Prediction of Metabolic Syndrome by Low Serum Testosterone Levels in Men , 2009, Diabetes.
[9] H. Völzke,et al. Reference ranges for serum dehydroepiandrosterone sulfate and testosterone in adult men. , 2008, Journal of andrology.
[10] J. Mckinlay,et al. Inverse association of testosterone and the metabolic syndrome in men is consistent across race and ethnic groups. , 2008, The Journal of clinical endocrinology and metabolism.
[11] A. Dobs,et al. Testosterone making an entry into the cardiometabolic world. , 2007, Circulation.
[12] M. Dowsett,et al. Endogenous Testosterone and Mortality Due to All Causes, Cardiovascular Disease, and Cancer in Men: European Prospective Investigation Into Cancer in Norfolk (EPIC-Norfolk) Prospective Population Study , 2007, Circulation.
[13] E. Nieschlag,et al. Androgen receptor gene CAG repeat length and body mass index modulate the safety of long-term intramuscular testosterone undecanoate therapy in hypogonadal men. , 2007, The Journal of clinical endocrinology and metabolism.
[14] A. Dominiczak,et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.
[15] Piotr Ponikowski,et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, European heart journal.
[16] T. Travison,et al. The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men. , 2007, The Journal of clinical endocrinology and metabolism.
[17] R. Jones,et al. Selective inhibition of L-type Ca2+ channels in A7r5 cells by physiological levels of testosterone. , 2006, Endocrinology.
[18] J. Lüdemann,et al. Regional disparities of hypertension prevalence and management within Germany , 2006, Journal of hypertension.
[19] E. Metter,et al. Relationship between androgenic hormones and arterial stiffness, based on longitudinal hormone measurements. , 2006, American journal of physiology. Endocrinology and metabolism.
[20] U. John,et al. Laboratory markers carbohydrate-deficient transferrin, gamma-glutamyltransferase, and mean corpuscular volume are not useful as screening tools for high-risk drinking in the general population: results from the Study of Health in Pomerania (SHIP). , 2004, Alcoholism, clinical and experimental research.
[21] C. Peers,et al. Testosterone is a potent inhibitor of L-type Ca(2+) channels. , 2004, Biochemical and biophysical research communications.
[22] R. Khalil,et al. Gender, sex hormones, and vascular tone. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.
[23] C. Bulpitt,et al. Systolic blood pressure variability as a risk factor for stroke and cardiovascular mortality in the elderly hypertensive population , 2003, Journal of hypertension.
[24] Daniel W. Jones,et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.
[25] D. Grobbee,et al. Grobbee Endogenous Sex Hormones and Cardiovascular Disease in Men Society , 2003 .
[26] W. Fraser,et al. Diurnal rhythms of serum total, free and bioavailable testosterone and of SHBG in middle‐aged men compared with those in young men , 2003, Clinical endocrinology.
[27] David Handelsman,et al. Androgens and cardiovascular disease. , 2003, Endocrine reviews.
[28] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.
[29] A. von Eckardstein,et al. Androgens and coronary artery disease. , 2003, Endocrine reviews.
[30] R. Collins,et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.
[31] Majid Ezzati,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .
[32] S. Oparil,et al. Sex hormones and hypertension. , 2002, Cardiovascular research.
[33] C. Hayward,et al. Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease. , 1999, Circulation.
[34] A. Kriska,et al. Longitudinal relation between endogenous testosterone and cardiovascular disease risk factors in middle-aged men. A 13-year follow-up of former Multiple Risk Factor Intervention Trial participants. , 1997, American journal of epidemiology.
[35] H. Turner,et al. Gonadal function in men with chronic illness , 1997, Clinical endocrinology.
[36] R. Francis,et al. Androgen supplementation in eugonadal men with osteoporosis-effects of 6 months of treatment on bone mineral density and cardiovascular risk factors. , 1996, Bone.
[37] L. Bang,et al. 24-h ambulatory blood pressure in 352 normal Danish subjects, related to age and gender. , 1995, American journal of hypertension.
[38] J. Vestbo,et al. Isolated systolic hypertension as a major risk factor for stroke and myocardial infarction and an unexploited source of cardiovascular prevention: a prospective population-based study. , 1995, Journal of human hypertension.
[39] J. Yarnell,et al. Endogenous sex hormones and ischemic heart disease in men. The Caerphilly prospective study. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.
[40] A. Vermeulen,et al. Representativeness of a single point plasma testosterone level for the long term hormonal milieu in men. , 1992, The Journal of clinical endocrinology and metabolism.
[41] E. Barrett-Connor,et al. Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study. , 1988, Circulation.
[42] E. Barrett-Connor,et al. Blood pressure and endogenous testosterone in men: an inverse relationship. , 1988, Journal of hypertension.
[43] S. Zeger,et al. Longitudinal data analysis using generalized linear models , 1986 .
[44] L. Kuller,et al. Relation between plasma high-density lipoprotein cholesterol and sex hormone concentrations in men. , 1984, The American journal of cardiology.
[45] F. Gyntelberg,et al. Coronary risk factors and plasma sex hormones. , 1982, The American journal of medicine.
[46] G. Balercia,et al. Pulse pressure, an index of arterial stiffness, is associated with androgen deficiency and impaired penile blood flow in men with ED. , 2009, The journal of sexual medicine.
[47] E. Barrett-Connor,et al. Low serum testosterone and mortality in older men. , 2008, The Journal of clinical endocrinology and metabolism.
[48] E. Barrett-Connor,et al. Association of endogenous testosterone with blood pressure and left ventricular mass in men. The Tromsø Study. , 2004, European journal of endocrinology.